Lehtonen A, Huupponen R, Himanen P
Int J Clin Pharmacol Ther Toxicol. 1984 Feb;22(2):86-90.
Carbohydrate and lipid metabolism at rest and after 1 h submaximal physical exercise in cold weather (between -1 and -6 C) were studied in ten healthy male subjects treated in a randomized double-blind fashion for 2 days with either placebo, the non-selective beta-adrenoceptor antagonist with high ISA pindolol (10 mg), or the cardioselective drug atenolol (100 mg). Four subjects, on both atenolol and pindolol, complained of muscular fatigue during exercise on beta blockade; four other subjects perceived some fatigue. There were no significant differences in blood glucose or insulin levels between treatments and placebo period. Post-exercise growth hormone levels increased on placebo (p less than 0.01), on pindolol (p less than 0.01), and on atenolol (p less than 0.05), but the alteration was more prominent on pindolol than on placebo (p less than 0.05). The plasma free fatty acid concentrations increased during exercise on placebo and pindolol (p less than 0.05) and on atenolol (p less than 0.01). Serum triglyceride concentrations decreased significantly during exercise on placebo or pindolol (p less than 0.01). Triglyceride levels before exercise were significantly higher on beta blockade than on placebo (p less than 0.05). The metabolic parameters taken before and after exercise did not explain the muscle fatigue experienced by many subjects during exercise.
在寒冷天气(-1至-6摄氏度)下,对10名健康男性受试者进行了研究,他们以随机双盲方式接受了2天的治疗,分别给予安慰剂、具有高内在活性(ISA)的非选择性β-肾上腺素能受体拮抗剂吲哚洛尔(10毫克)或心脏选择性药物阿替洛尔(100毫克),研究了静息状态以及次最大强度体育锻炼1小时后的碳水化合物和脂质代谢情况。服用阿替洛尔和吲哚洛尔的4名受试者在β受体阻滞剂作用下运动时抱怨肌肉疲劳;另外4名受试者感觉到了一些疲劳。各治疗组与安慰剂期之间的血糖或胰岛素水平无显著差异。运动后生长激素水平在安慰剂组(p<0.01)、吲哚洛尔组(p<0.01)和阿替洛尔组(p<0.05)均升高,但吲哚洛尔组的变化比安慰剂组更显著(p<0.05)。安慰剂组、吲哚洛尔组运动期间血浆游离脂肪酸浓度升高(p<0.05),阿替洛尔组运动期间血浆游离脂肪酸浓度升高(p<0.01)。安慰剂组或吲哚洛尔组运动期间血清甘油三酯浓度显著降低(p<0.01)。运动前甘油三酯水平在β受体阻滞剂作用下显著高于安慰剂组(p<0.05)。运动前后的代谢参数无法解释许多受试者在运动期间经历的肌肉疲劳。